India will mass produce US COVID-19 vaccines as Quad sets ambitious target of 1 billion doses by end-2022
India to play key role in historic Quad COVID-19 vaccine partnership
India will mass produce US COVID-19 vaccines as Quad sets ambitious target of 1 billion doses by end-2022